Development of Novel Epigenetic Chimeric Entities Against Cancer Cells

Our research group specializes in synthesizing and characterizing hybrid chemical entities with potential dual activity. These novel compounds feature distinct functional groups within their chemical structure, each targeting different therapeutic targets. As a student, you will have the opportunity to gain significant hands-on experience in synthesizing and characterizing these innovative entities with epigenetic activity, as well as evaluating their effects in vitro.